Kiniksa Pharmaceuticals International, plc Operating Lease, Liability, Current
Kiniksa Pharmaceuticals International, plc (KNSA) had Operating Lease, Liability, Current of $3.17 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-04-28
- 2026-03-31: Operating Lease, Liability, Current $3.17M.
- 2025-12-31: Operating Lease, Liability, Current $2.99M.
- 2025-09-30: Operating Lease, Liability, Current $2.70M.
- 2025-06-30: Operating Lease, Liability, Current $2.52M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-03-31 | $3.17M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $2.99M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $2.70M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $2.52M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $2.29M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $1.99M 10-K · filed 2026-02-24 |
| 2024-09-30 | $2.03M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $2.08M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $2.28M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $2.25M 10-K · filed 2025-02-25 |
| 2023-09-30 | $2.31M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $2.24M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $3.48M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $3.30M 10-K · filed 2024-02-28 |
| 2022-09-30 | $3.27M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.34M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.31M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $3.38M 10-K · filed 2023-03-02 |
| 2021-09-30 | $3.25M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $2.64M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $2.37M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.11M 10-K · filed 2022-02-24 |
| 2020-09-30 | $1.49M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.68M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $1.69M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $1.70M 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.61M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $1.50M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $1.38M 10-Q · filed 2019-05-07 |